期刊文献+

阿托伐他汀治疗老年2型糖尿病高脂血症临床观察 被引量:5

The Effects of Atorvastatin In Elderly Patients with Type~2 Diabetes with Hyper Lipidaemia
暂未订购
导出
摘要 目的探讨阿托伐他汀对老年2型糖尿病并高脂血症患者降脂疗效及安全性。方法选取年龄≥60岁老年2型糖尿病高脂血症122例门诊病人,分为服用阿托伐他汀组66例(A组),服用普伐他汀组56例(B组),分别治疗8周。比较治疗2组前后相关临床参数:血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白(LDL-C)、以及空腹血糖(FBS)、谷丙转氨酶(ALT)、肌酸激酶(CK)。结果2组治疗后TC、TG、LDL-C与治疗前相比下降,差异有显著性;治疗后HDL~C与治疗前相比上升,差异有显著性;ALT、CK相对稳定;2组之间差异无显著性。结论阿托伐他汀是治疗老年2型糖尿病高脂血症患者安全而有效的药物。 Objective To study the effects of atorvastatin in elderly patients with type-2 diabetes with hyper lipidaemia. Methods 122 Elderly type 2 diabetes complicated hyper lipidaemia were selected and were divided into two groups,including 66 diabetes (group A),56 diabetes(group B). Atorvastatin and Pravastatin were given for an average period of 8wk,its effect were compared with. The levels of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipeprotein cholesterol (LDL-C), and triglycerides (TG) were examined before and after treatment. Results after Atorvastiatin and Pravastat therorpy,the levels of TC,TG,LDL-C significantly decreased;HDL-C increased;ALT and CK have no obvious diference. Conclusion The results suggest that atorvastatin can decrease blood lipid level safety.
机构地区 北京市海淀医院
出处 《中外医疗》 2009年第25期74-76,共3页 China & Foreign Medical Treatment
关键词 阿托伐他汀 老年糖尿病 高脂血症 Atorvastatin Elderly patients with type--2 diabetes Hyperlipidaemia
  • 相关文献

参考文献8

  • 1中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南.,2007:5.
  • 2MeGarry JD. Dysregulation of fatty acide metabolism in the etiology of type 2 diabetes[J].Diabetes, 2001,50(Supp 12):6.
  • 3Grundy SM,Benjamin IJ,Burke GJ,et al. Diabetes and cardiovascular disease. A statement.for healtheare professionals form the American Heart Association[J].Circulation,1999,100:1134.
  • 4Lyons TJ. Lipoprotein glycation and its metabolic consequences[J]. Diabetes, 1992,41 (supp 12):67 - 73.
  • 5EndoA.The discovery and development of HMG-CoA Reductase inhibitor[J].J Lip Research,1992,33:1569.
  • 6Funatsu T,Kakuta H,Tanaka H,et al. Atorvastatin (Lipitor):a review of its pharmacological and clinical profile[J].Nippon Yakurigaku Zasshi,2001,117(1):65.
  • 7Yamaoto A,Harada- Shiba M, Kawaguchi A, et al.Apheresis technology for prevention and regression of. ather-osclerosis [J].Ther Apher,2001,5(4):221 - 225.
  • 8Rosenson RS,Tangney CC Antiat herothrombotic properties of statins:implications,for cardiovasular event reduction[J].JAMA, 1998,279(20):1643- 1650.

同被引文献35

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部